With extensive updated information on everything from treatment of hypertension to orphan drugs, AHFS® Drug Information® 2019 Edition is a necessary addition to your pharmacy’s resources.
With expanded and revised content supported by more than 92,000 references and incorporating the advice of numerous subject matter experts, AHFS® DI® helps you protect your patients and your practice. It’s the only print compendium designated by the U.S. Congress, the only compendium published by a professional and scientific society, and is the reference that has been trusted by pharmacists and other healthcare professionals for over 60 years.
AHFS® DI® contains the most trustworthy drug information available—all in one place. It is the most comprehensive evidence-based source of drug information complete with therapeutic guidelines and off-label uses.
Updates for this edition include:
- Important updated monographs and references related to revised therapeutic guidelines, including revised recommendations for treatment of hypertension, including discussions of controversies in blood pressure threshold for initiating antihypertensive drug therapy and specific treatment goals
- Newly published information on breakthrough oncology drugs approved as part of the FDA’s accelerated approval program
- Coverage of the 2018-2019 recommendations from the Institute for Safe Medication Practices (ISMP) on targeted medication safety best practices for hospitals
- Information about vaccines and other immunizing agents, including recommendations for travelers
Learn more about related resources, electronic only monographs, and AHFS Clinical Drug Information at ahfsdruginformation.com.